Laddar...
Intracisternal administration of tanshinone IIA-loaded nanoparticles leads to reduced tissue injury and functional deficits in a porcine model of ischemic stroke
BACKGROUND: The absolute number of new stroke patients is annually increasing and there still remains only a few Food and Drug Administration (FDA) approved treatments with significant limitations available to patients. Tanshinone IIA (Tan IIA) is a promising potential therapeutic for ischemic strok...
Sparad:
| I publikationen: | IBRO Neurosci Rep |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Elsevier
2021
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8019951/ https://ncbi.nlm.nih.gov/pubmed/33842909 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ibneur.2020.11.003 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|